tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLYS Stock Latest News

3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
Market News3 Best Stocks to Buy Now, 4/1/2025, According to Top Analysts
22h ago
DAVE
ENVX
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
PremiumCompany Announcements
Mineralys Therapeutics Unveils Promising Trial Results for Lorundrostat
2d ago
8K
MLYS
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
2d ago
TLN
BRZE
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
PremiumThe Fly
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
2d ago
MLYS
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
PremiumRatings
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
3d ago
MLYS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
12d ago
INO
ARCT
Buy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile
Premium
Ratings
Buy Rating Justified for Mineralys Therapeutics, Inc. Due to Promising Study Results and Manageable Safety Profile
13d ago
MLYS
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
16d ago
LAC
QSR
Mineralys Therapeutics announces data from Phase 2 Advance-HTN trial
PremiumThe Fly
Mineralys Therapeutics announces data from Phase 2 Advance-HTN trial
16d ago
MLYS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
19d ago
WW
FRO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
21d ago
AEON
APRE
Mineralys Therapeutics 12.96M share Secondary priced at $13.50
PremiumThe Fly
Mineralys Therapeutics 12.96M share Secondary priced at $13.50
21d ago
MLYS
Mineralys Therapeutics announces $250M common stock offering
PremiumThe FlyMineralys Therapeutics announces $250M common stock offering
22d ago
MLYS
Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes
Premium
Ratings
Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes
23d ago
MLYS
Promising Potential of Lorundrostat Drives Buy Rating for Mineralys Therapeutics, Inc.
Premium
Ratings
Promising Potential of Lorundrostat Drives Buy Rating for Mineralys Therapeutics, Inc.
23d ago
MLYS
Mineralys Therapeutics Reports Positive Phase 3 Trial Results
PremiumCompany Announcements
Mineralys Therapeutics Reports Positive Phase 3 Trial Results
23d ago
8K
MLYS
Mineralys Therapeutics announces results from Launch-HTN, Advance-HTN trials
PremiumThe Fly
Mineralys Therapeutics announces results from Launch-HTN, Advance-HTN trials
23d ago
MLYS
Buy Rating for Mineralys Therapeutics, Inc. Driven by Lorundrostat’s Potential in Hypertension Treatment
PremiumRatings
Buy Rating for Mineralys Therapeutics, Inc. Driven by Lorundrostat’s Potential in Hypertension Treatment
27d ago
MLYS
3 Best Stocks to Buy Now, 2/26/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 2/26/2025, According to Top Analysts
1M ago
BABA
BLZE
Mineralys Therapeutics Highlights Positive Earnings Call
PremiumCompany AnnouncementsMineralys Therapeutics Highlights Positive Earnings Call
2M ago
MLYS
Promising Outlook for Mineralys Therapeutics: Buy Rating Affirmed on Lorundrostat’s Potential
Premium
Ratings
Promising Outlook for Mineralys Therapeutics: Buy Rating Affirmed on Lorundrostat’s Potential
2M ago
MLYS
Mineralys Therapeutics Reports 2024 Earnings and Trial Progress
Premium
Company Announcements
Mineralys Therapeutics Reports 2024 Earnings and Trial Progress
2M ago
MLYS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >